Courtney Nelson Wills - 11 Mar 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Role
Senior Vice President, General Counsel
Signature
/s/ Bryan F. Kelly, attorney-in-fact
Issuer symbol
MMED
Transactions as of
11 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 19:26:16 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wills Courtney Nelson Senior Vice President, General Counsel C/O 18000 DEVONSHIRE STREET, NORTHRIDGE /s/ Bryan F. Kelly, attorney-in-fact 13 Mar 2026 0002110477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMED Common Stock Award +18,082 18,082 11 Mar 2026 Direct F1, F2, F3, F4
transaction MMED Common Stock Award +955 955 11 Mar 2026 Direct F1, F2, F4, F5
transaction MMED Common Stock Award +11,486 11,486 11 Mar 2026 Direct F1, F2, F4, F6
transaction MMED Common Stock Award +5,151 5,151 11 Mar 2026 Direct F1, F2, F4, F7
transaction MMED Common Stock Award +13,646 13,646 11 Mar 2026 Direct F1, F2, F4, F8
transaction MMED Common Stock Award +5,743 5,743 11 Mar 2026 Direct F1, F2, F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").
F2 Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").
F3 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027.
F4 Includes shares to be issued in connection with the vesting of one or more restricted stock units.
F5 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027.
F6 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028.
F7 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026.
F8 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027.
F9 Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028.

Remarks:

Senior Vice President, General Counsel